≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Malignant neoplasm of other and ill-defined digestive organs

DOID Endpoint Browser

C3_DIGESTIVE_ORGANS_NAS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cause of death: ICD-10 — C26
  • Cause of death: ICD-9 — 15[8-9]
  • Cause of death: ICD-8 — 15[8-9]
  • Cancer registry: Topography ICD-O-3 — C26
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 3

2 out of 7 registries used, show all original rules.

248

4. Check minimum number of events

None

248

5. Include endpoints

None

248

6. Filter based on genotype QC (FinnGen only)

248

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF9

Similar endpoints

↥

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 248 110 138
Unadjusted period prevalence (%) 0.05 0.04 0.06
Median age at first event (years) 74.36 76.31 72.81

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
231
Matched controls
2310
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8140/3-C26.9
ICD-O-3
Adenocarcinoma, NOS, of gastrointestinal tract, NOS
+∞
85.9
77
*
C26.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the digestive system
396.7
83.4
79
*
130
Kela drug reimbursment
Malignant tumour
15.4
58.6
107
122
Z51.5
ICD-10 Finland
Palliative care
14.4
43.8
79
80
C26.0
ICD-10 Finland
Malignant neoplasm: Intestinal tract, part unspecified
461.3
40.4
39
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
23.4
38.6
56
31
8000/3-C26.9
ICD-O-3
Neoplasm, malignant of gastrointestinal tract, NOS
+∞
37.5
35
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
29.1
34.8
47
20
N02AA05
ATC
oxycodone; systemic
6.6
31.9
99
236
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
16.0
31.3
52
41
A04AA02
ATC
granisetron; systemic, transdermal
13.2
29.8
54
52
A03FA01
ATC
metoclopramide; systemic, rectal
5.4
27.8
105
308
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
46.0
26.6
32
8
H02AB02
ATC
dexamethasone; systemic
7.2
24.0
63
114
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
19.3
21.2
32
19
L01BC06
ATC
capecitabine; oral
12.0
19.5
36
35
JN4BD
NOMESCO Finland
Extensive body CT
5.1
17.8
62
155
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
12.1
17.1
31
29
C80.92
ICD-10 Finland
Malignant tumor without specified localization adenocarcinoma
+∞
16.9
16
*
C26.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of digestive system
182.4
16.7
17
*
8140/3-C26.0
ICD-O-3
Adenocarcinoma, NOS, of intestinal tract, NOS
+∞
15.8
15
*
JN4AD
NOMESCO Finland
Body CT examination
5.8
15.2
45
92
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
12.6
14.2
25
22
8000/3-C26.0
ICD-O-3
Neoplasm, malignant of intestinal tract, NOS
+∞
13.7
13
*
R18
ICD-10 Finland
Ascites
12.6
13.6
24
21
WF049
NOMESCO Finland
Radiotherapy of metastasis
10.7
13.6
26
27
JAH00
NOMESCO Finland
Laparotomy
9.6
12.9
26
30
8010/3-C26.9
ICD-O-3
Carcinoma, NOS, of gastrointestinal tract, NOS
+∞
12.6
12
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
5.9
12.3
35
68
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
17.6
11.9
18
11
8936/3-C26.9
ICD-O-3
Gastrointestinal stromal tumor of gastrointestinal tract, NOS
+∞
11.5
11
*
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
17.7
10.0
15
9
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
21.1
9.9
14
7
A04AA01
ATC
ondansetron; systemic, rectal
4.8
9.7
32
74
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
104.0
9.5
10
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
9.3
92
477
A06AH03
ATC
naloxegol; oral
28.7
8.6
11
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
21.0
8.6
12
6
C76.2
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Abdomen
93.2
8.5
9
*
WZC30
NOMESCO Finland
Teaching
3.2
8.1
44
157
WX302
NOMESCO Finland
Thoracal epidural anesthesy
5.0
7.8
24
52
H01CB03
ATC
lanreotide; parenteral
46.5
7.8
9
*
C49.49
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen other or unspecified tumor
46.5
7.8
9
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.3
7.4
83
452
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
+∞
7.3
7
*
D77
ICPC
Malignant digestive neopl other/NOS
31.0
7.2
9
*
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
31.0
7.2
9
*
B01AB10
ATC
tinzaparin; parenteral
3.7
7.0
30
90
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.0
7.0
40
149
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.9
6.8
43
171
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.9
6.5
26
73
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
6.5
63
316
189
Kela drug reimbursment
Imatinib
71.7
6.5
7
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
9.7
6.4
12
13
8240/3-C26.9
ICD-O-3
Neuroendocrine tumor, NOS, of gastrointestinal tract, NOS
+∞
6.3
6
*
8480/3-C26.9
ICD-O-3
Mucinous adenocarcinoma of gastrointestinal tract, NOS
+∞
6.3
6
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.8
6.2
42
172

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
135
227
11.85
87.73
3.7
4.3
ug/l
203.1
72.4
0.95
121
193
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
75
88
11.78
62.36
3.5
3.4
u/ml
6133.3
1472.1
0.98
65
75
(4035726)
81
163
6.89
41.43
1.5
1.4
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
33
29
12.97
32.46
1.8
1.5
ug/l
19.8
16.0
0.51
33
29
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
28
22
14.21
29.35
4.5
3.5
nmol/l
9.3
4.1
0.43
28
22
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
42
72
6.82
24.42
2.0
2.3
u/ml
189.0
52.3
2.31
42
66
(40768441) Liver Pathology biopsy report
19
17
12.02
18.19
1.1
1.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
169
1008
3.12
15.85
13.0
6.1
umol/l
16.2
11.7
1.40
164
948
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
117
577
2.94
15.49
2.9
2.4
u/l
42.5
56.5
6.68
108
537
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
15
7
22.67
10.81
6.1
5.7
nmol/l
186.5
116.1
—
15
7
(3024561) Albumin [Mass/volume] in Serum or Plasma
141
869
2.44
10.71
7.8
4.4
g/l
30.7
34.6
8.78
135
804
(3013650) Neutrophils [#/volume] in Blood by Automated count
156
1019
2.43
10.22
15.0
8.7
e9/l
5.3
4.3
3.10
141
884
(3023368) Bacteria identified in Blood by Culture
110
623
2.37
9.91
4.4
4.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
12
16
7.83
8.48
1.3
1.3
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
13
20
6.80
8.14
1.2
1.3
e6/l
47858.6
63000.4
—
7
13
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
48
214
2.54
7.06
3.4
2.8
umol/l
19.9
9.8
1.00
48
186
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
77
425
2.18
6.94
2.5
2.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
128
854
2.03
6.93
6.3
10.4
inr
1.3
1.4
0.31
39
239
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
122
811
1.99
6.57
4.6
4.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
77
433
2.13
6.57
13.7
6.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
11
18
6.35
6.48
1.0
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
131
1699
0.51
6.13
3.5
5.2
mmol/l
2.6
2.6
0.19
111
1526
(3044640) Blood type and Crossmatch panel - Blood
94
582
1.99
6.11
2.7
2.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
13
27
5.02
6.04
1.6
1.6
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
10
16
6.47
6.00
5.9
3.1
u/ml
68.5
108.4
—
10
16
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
22
71
3.30
5.77
3.3
2.2
u/ml
0.4
0.3
0.76
16
41
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
127
1648
0.53
5.67
3.2
4.6
mmol/l
4.5
4.5
0.19
110
1494
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
127
1638
0.54
5.38
3.1
4.6
mmol/l
1.4
1.4
0.67
112
1467
(3012441) Differential panel - Pleural fluid
11
22
5.18
5.31
1.3
1.5
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
179
1420
1.93
5.11
15.3
7.5
u/l
132.5
80.6
7.20
170
1313
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
124
1587
0.56
4.74
2.9
4.1
mmol/l
1.4
1.3
0.68
106
1413
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
54
874
0.51
4.58
2.4
2.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
136
1691
0.57
4.57
3.3
4.9
mmol/l
6.2
6.1
0.35
112
1506
(1761868) Lipid panel - Serum or Plasma
25
531
0.41
4.47
2.5
3.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
130
960
1.74
4.44
6.1
6.5
mmol/l
1.2
1.2
0.42
105
792
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
128
1611
0.57
4.40
5.4
6.4
mmol/mol
43.1
41.4
0.97
110
1478
(3022096) Basophils/100 leukocytes in Blood
110
780
1.74
4.30
5.1
5.4
%
0.5
0.6
1.59
103
715
(40768797) Stomach Pathology biopsy report
43
226
2.09
4.25
1.3
1.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
121
887
1.71
4.16
6.0
5.6
mmol/l
1.2
1.2
0.85
116
785
(3018418) pH of Serum or Plasma
87
582
1.76
4.15
5.5
4.2
ph
7.4
7.4
0.72
21
108
(3003694) ABO and Rh group [Type] in Blood
65
403
1.83
3.97
1.3
1.3
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
111
803
1.69
3.95
5.3
5.4
%
2.2
2.8
2.35
104
738
(42870588) Differential panel, method unspecified - Blood
85
578
1.72
3.77
4.6
5.4
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
110
806
1.65
3.66
5.5
5.7
%
9.0
8.8
0.20
104
746
(3002030) Lymphocytes/100 leukocytes in Blood
111
821
1.64
3.52
5.4
5.6
%
20.0
26.1
5.84
102
750
(3006315) Basophils [#/volume] in Blood
115
860
1.63
3.48
5.1
5.3
e9/l
0.0
0.0
0.00
102
742
(3018010) Neutrophils/100 leukocytes in Blood
109
805
1.63
3.47
5.2
5.3
%
64.9
58.6
5.06
100
739
(3019198) Lymphocytes [#/volume] in Blood
116
879
1.60
3.27
5.2
5.4
e9/l
1.4
1.9
3.35
103
773
(3013115) Eosinophils [#/volume] in Blood
117
892
1.59
3.19
5.2
5.4
e9/l
0.2
0.2
1.53
103
781
(3022217) INR in Platelet poor plasma by Coagulation assay
52
321
1.78
3.18
11.6
29.4
inr
1.8
1.3
—
7
32
(3001604) Monocytes [#/volume] in Blood
113
855
1.59
3.18
5.2
5.3
e9/l
0.7
0.6
1.45
101
733
(3018677) aPTT in Platelet poor plasma by Coagulation assay
51
316
1.77
3.08
2.4
1.8
s
29.5
29.6
0.06
51
302
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
13
48
2.80
2.76
1.3
1.5
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
140
1142
1.52
2.65
4.6
4.5
mmol/l
7.1
6.8
0.84
132
1083
(3035880) pH of Pleural fluid
6
11
5.56
2.55
1.0
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
12
47
2.63
2.30
1.3
1.2
—
—
—
0
0
(4281824)
6
14
4.36
2.16
1.7
1.0
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
15
68
2.28
2.15
3.9
3.3
g/l
0.2
0.2
—
10
23
(3014576) Chloride [Moles/volume] in Serum or Plasma
43
281
1.64
2.14
4.6
5.6
mmol/l
101.2
103.9
1.80
43
270
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
28
449
0.58
2.04
3.7
3.1
ug/l
0.8
0.9
0.04
18
309
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
11
44
2.57
2.04
1.5
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
11
44
2.57
2.04
1.5
1.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
40
586
0.62
2.03
3.7
3.8
mg/mmol
28.2
10.2
0.35
22
387
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
7
22
3.24
1.89
1.3
1.4
u/l
435.1
342.6
—
7
22
(40768804) Tissue Pathology biopsy report
87
680
1.43
1.88
2.4
2.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
41
276
1.58
1.82
1.6
1.9
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
39
558
0.64
1.76
3.2
2.9
mmol/l
8.7
7.4
0.50
27
458
(1002224) Polysomnography panel
0
47
0.00
1.72
0.0
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
17
298
0.54
1.69
1.2
1.4
g/l
2.2
2.8
1.04
11
173
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
137
1558
0.73
1.65
3.4
4.6
mu/l
1.9
2.0
0.33
121
1361
(3012516) Albumin [Mass/volume] in Urine
39
548
0.66
1.61
3.4
3.0
mg/l
1368.3
63.1
0.52
23
368
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
23
138
1.73
1.58
1.4
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
145
1628
0.74
1.55
27.7
16.3
ml/min/173m2
76.5
72.2
1.23
130
1330
(3002032) Base excess in Venous blood by calculation
31
203
1.60
1.55
3.2
4.1
mmol/l
3.0
1.6
0.65
25
163
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
15
3.38
1.53
1.0
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
9
40
2.30
1.41
1.6
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
7
29
2.45
1.40
1.9
4.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
0
37
0.00
1.35
0.0
1.2
—
3.2
—
0
7
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
0
38
0.00
1.35
0.0
1.2
—
1.7
—
0
8
(3000991) Gas panel - Venous blood
27
178
1.58
1.33
5.3
6.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
24
154
1.62
1.31
1.5
1.7
—
—
—
0
0
(3012544) pH of Venous blood
30
204
1.53
1.30
3.3
4.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
24
155
1.61
1.28
4.7
4.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
21
321
0.62
1.27
1.2
1.2
u/ml
0.7
0.9
—
8
85
(3027801) Oxygen [Partial pressure] in Arterial blood
36
256
1.47
1.27
3.7
5.8
kpa
11.5
11.5
0.01
36
244
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
36
256
1.47
1.27
3.7
5.9
kpa
5.0
5.0
0.01
36
243
(3044927) Protein electrophoresis panel - Urine
5
19
2.66
1.22
1.0
1.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
6
126
0.46
1.20
1.3
3.0
g/l
9.9
10.2
—
6
111
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
34
0.00
1.17
0.0
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
0
34
0.00
1.17
0.0
1.1
—
233.4
—
0
15
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
49
625
0.73
1.16
3.7
4.6
%
23.9
21.9
0.29
23
323
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
36
0.00
1.15
0.0
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
35
255
1.43
1.10
3.6
5.9
mmol/l
1.5
1.3
0.10
29
197
(3021960) Folate [Moles/volume] in Serum or Plasma
38
497
0.72
1.05
1.2
1.7
nmol/l
21.0
20.5
0.06
32
416
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
22
2.30
1.04
1.2
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
46
356
1.36
1.03
1.8
1.9
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
67
804
0.77
1.03
1.6
2.1
pmol/l
83.4
92.3
0.84
34
410
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
29
0.00
0.98
0.0
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
32
0.00
0.95
0.0
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
15
230
0.63
0.94
2.6
4.6
%
28.0
31.5
—
6
148
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
11
182
0.59
0.94
1.1
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
15
94
1.63
0.93
6.4
7.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
59
710
0.78
0.91
1.9
2.4
nmol/l
71.2
78.0
0.83
50
610
(3022621) pH of Urine by Test strip
7
129
0.53
0.91
2.4
2.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
67
793
0.79
0.90
3.9
5.1
ug/l
2.5
2.8
0.20
58
696
(3022806) Fractional oxyhemoglobin in Capillary blood
6
29
2.09
0.90
1.8
2.3
%
91.1
89.1
—
6
29
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
98
854
1.24
0.90
3.4
4.5
ng/l
32.8
48.2
1.10
77
653
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
31
1.96
0.85
3.0
3.1
%
69.3
61.8
—
6
31
(36304419) Bacteria [Presence] in Urine
64
535
1.26
0.83
3.5
3.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
12
73
1.68
0.83
1.0
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
113
1254
0.82
0.83
3.0
3.7
pmol/l
15.4
15.0
0.96
96
1085
(3008152) Bicarbonate [Moles/volume] in Arterial blood
22
156
1.45
0.82
3.7
6.6
mmol/l
25.9
24.6
0.78
22
144
(3026782) Osmolality of Urine
53
435
1.28
0.80
2.7
3.3
mosm/kgh2o
465.4
552.2
3.05
48
369
(1616796) Gas panel - Central venous blood
8
48
1.69
0.79
2.4
3.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
117
1050
1.22
0.79
3.4
3.1
u/l
124.0
54.0
2.75
110
967
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
33
255
1.34
0.77
1.7
1.8
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
28
0.00
0.76
0.0
1.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
79
903
0.82
0.76
3.6
4.4
estimate
0.0
0.0
0.00
22
167
(3028026) IgM [Mass/volume] in Serum or Plasma
6
106
0.56
0.74
1.0
1.6
g/l
0.9
1.2
—
6
91
(3009261) Glucose [Presence] in Urine by Test strip
80
911
0.82
0.74
3.6
4.5
estimate
0.0
0.0
0.00
22
159
(3036489) Thrombin time
10
60
1.69
0.73
3.8
1.9
s
22.5
20.4
—
10
54
(3021589) Normoblasts [#/volume] in Blood
88
773
1.21
0.73
11.8
10.6
e9/l
0.0
0.0
0.40
76
630
(40761511) CBC panel - Blood by Automated count
168
1782
0.82
0.72
21.3
16.8
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
7
43
1.65
0.67
1.7
1.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
28
1.80
0.66
3.4
2.5
e9/l
6.6
4.9
—
5
28
(3021601) Nitrite [Presence] in Urine by Test strip
80
902
0.83
0.65
4.8
6.0
estimate
0.0
0.0
0.00
23
164
(3044889) 12 lead EKG panel
114
1245
0.84
0.65
3.9
4.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
22
166
1.36
0.61
2.6
3.9
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
0
20
0.00
0.60
0.0
1.5
—
3.1
—
0
7
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
0
21
0.00
0.60
0.0
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
11
72
1.55
0.60
2.4
3.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
5
86
0.57
0.57
2.2
3.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
28
222
1.29
0.57
4.3
4.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
35
423
0.80
0.56
2.7
4.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
6
38
1.59
0.54
1.2
1.7
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
35
421
0.80
0.54
3.7
5.0
kg/l
1.0
1.0
—
8
60
(3020891) Body temperature
14
101
1.41
0.50
2.1
4.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
63
710
0.85
0.50
2.3
2.9
ug/l
441.5
147.3
0.61
56
644
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
12
84
1.45
0.50
1.8
2.2
—
—
—
0
0
(3019225) pH of Specimen
23
181
1.30
0.50
3.0
4.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
7
45
1.57
0.49
2.0
2.4
—
—
—
0
0
(3002256) Pathology report gross observation
27
218
1.27
0.49
1.2
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
11
76
1.47
0.49
1.5
1.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
71
635
1.16
0.47
3.4
3.6
e6/l
81.1
168.1
0.35
54
503
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
60
530
1.17
0.46
2.0
2.2
mg/l
3.1
3.3
0.44
51
460
(40768443) Skin Pathology biopsy report
5
84
0.59
0.46
1.0
1.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
130
1381
0.88
0.45
31.5
21.2
%
14.9
14.0
5.45
130
1347
(3022948) Iron [Moles/volume] in Serum or Plasma
39
335
1.19
0.41
1.6
2.6
umol/l
13.1
12.4
0.18
33
305
(3010813) Leukocytes [#/volume] in Blood
182
1886
0.87
0.41
35.2
25.1
e9/l
8.0
7.0
3.78
173
1817
(3026361) Erythrocytes [#/volume] in Blood
182
1886
0.87
0.41
35.1
25.1
e12/l
4.1
4.4
10.60
174
1819
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
30
251
1.22
0.41
1.7
1.7
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
15
0.00
0.41
0.0
4.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3035941) MCH [Entitic mass]
182
1885
0.87
0.40
35.0
25.0
pg
29.9
30.4
1.72
176
1850
(3024731) MCV [Entitic volume]
182
1885
0.87
0.40
35.0
25.0
fl
91.1
91.7
0.60
176
1850
(3007461) Platelets [#/volume] in Blood
182
1885
0.87
0.40
35.2
25.1
e9/l
280.6
238.1
6.63
173
1826
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
182
1751
1.15
0.40
26.6
17.5
mg/l
44.5
25.7
5.98
173
1443
(46235355) HIV 1 and 2 tests - Meaningful Use set
14
181
0.76
0.39
1.2
1.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
40
458
0.85
0.39
1.7
1.8
pmol/l
362500501.5
436.1
0.49
32
381
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
25
208
1.22
0.37
1.7
2.8
ug/l
3.2
7.2
1.72
17
183
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
6
41
1.47
0.36
1.0
1.8
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
14
108
1.31
0.36
1.4
3.9
mmol/l
2.2
1.4
0.91
14
103
(3020564) Creatinine [Moles/volume] in Serum or Plasma
176
1821
0.88
0.35
31.6
20.4
umol/l
81.5
85.0
0.75
176
1821
(4010399)
10
133
0.74
0.34
1.3
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
10
133
0.74
0.34
2.2
1.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
12
93
1.30
0.30
1.2
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
12
149
0.80
0.26
1.3
4.0
%
1.9
0.9
—
7
57
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
31
350
0.87
0.26
3.1
3.0
e6/l
2.9
1.4
0.36
12
203
(1761482) Bacteria [#/volume] in Urine by Culture
5
75
0.66
0.26
2.0
6.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
20
234
0.84
0.26
1.8
1.7
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
62
573
1.11
0.26
3.6
3.5
e6/l
1.2
0.4
1.73
46
440
(3037467) Urinalysis macro (dipstick) panel - Urine
131
1256
1.09
0.25
4.0
4.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
67
717
0.91
0.24
3.8
4.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
11
136
0.80
0.24
1.5
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
76
713
1.09
0.23
3.6
4.2
e6/l
71.1
104.6
0.41
55
535
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
13
106
1.24
0.23
5.2
7.2
mmol/l
24.2
24.8
0.40
13
96
(3022145) Colonoscopy Study observation
23
200
1.16
0.23
1.3
1.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
5
39
1.29
0.23
1.2
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
7
94
0.74
0.23
1.3
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
7
95
0.73
0.22
1.3
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
41
1.22
0.22
1.0
3.1
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
5
41
1.22
0.22
3.0
1.2
g/l
0.2
0.2
—
5
41
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
12
145
0.82
0.21
1.4
1.5
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(44806420)
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
2.7
—
—
—
0
0
(4027681)
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
(3004451) EKG impression Narrative
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3000012) Reticulocyte production index
0
12
0.00
0.21
0.0
2.7
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.6
—
0.9
—
0
12
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
5
43
1.17
0.21
3.4
1.2
g/l
1.1
1.1
—
5
43
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
0
13
0.00
0.21
0.0
1.3
—
3.5
—
0
8
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
33
298
1.12
0.20
1.8
2.5
%
28.6
21.6
0.65
23
256
(3000330) Specific gravity of Urine by Test strip
9
113
0.79
0.20
1.9
5.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
48
1.26
0.20
1.8
1.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
6
49
1.23
0.20
1.0
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
15
175
0.85
0.19
2.4
4.0
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
11
91
1.22
0.18
1.5
3.6
mmol/l
3.5
4.0
2.31
11
80
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
68
717
0.93
0.17
2.9
3.4
ng/l
1773.6
1863.0
0.07
59
601
(4034850)
8
69
1.16
0.16
10.4
12.6
—
—
—
0
0
(3013512) EKG study
56
593
0.93
0.16
3.9
4.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
6
79
0.75
0.15
1.0
1.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
13
148
0.87
0.13
1.2
1.7
%
1.5
1.6
—
8
120
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
77
740
1.06
0.13
3.3
3.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
12
104
1.16
0.12
1.8
3.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
12
137
0.87
0.12
1.4
1.6
—
—
—
0
0
(3000492) Spirometry study
12
137
0.87
0.12
1.3
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
54
1.11
0.09
1.0
1.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
54
1.11
0.09
1.0
1.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
20
215
0.92
0.08
1.3
1.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
78
1.03
0.07
1.0
2.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
66
641
1.04
0.07
2.5
3.8
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
181
1828
0.96
0.07
28.8
20.5
mmol/l
4.0
4.0
0.06
175
1770
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
180
1818
0.96
0.07
17.8
10.8
u/l
33.2
24.4
2.71
172
1734
(3021879) Hepatitis B virus core Ab [Presence] in Serum
8
91
0.87
0.07
1.4
1.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
47
455
1.04
0.05
1.8
1.8
nmol/l
1169.5
1211.7
0.08
39
340
(3026493) Urate [Moles/volume] in Serum or Plasma
50
486
1.04
0.05
3.4
2.8
umol/l
7414.9
9293.0
0.09
41
405
(3013707) Erythrocyte sedimentation rate by Westergren method
130
1315
0.98
0.04
3.2
4.1
mm/h
24.5
14.3
4.21
118
1190
(3009542) Hematocrit [Volume Fraction] of Blood
149
1475
1.02
0.04
25.1
18.1
%
36.4
39.0
2.63
97
937
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
32
331
0.96
0.04
3.1
3.3
e6/l
4.2
2.9
0.33
13
185
(3019550) Sodium [Moles/volume] in Serum or Plasma
181
1822
0.97
0.04
28.5
20.5
mmol/l
138.0
139.6
9.48
175
1762
(3002179) Metamyelocytes/100 leukocytes in Blood
12
128
0.93
0.02
1.3
4.0
%
0.6
0.5
—
5
40
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
25
242
1.04
0.02
10.8
9.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
11
117
0.94
0.02
1.9
2.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
15
144
1.04
0.00
1.1
2.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
37
376
0.98
0.00
2.2
4.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
14
145
0.96
0.00
1.2
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
51
513
0.99
0.00
4.1
4.7
estimate
0.0
0.0
0.00
19
158
(3041096) Erythrocytes [Presence] in Urine by Automated
50
499
1.00
0.00
4.4
4.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
16
159
1.01
0.00
5.8
3.3
ml/min/173m2
57.6
55.6
—
5
72
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
58
0.86
0.00
1.0
1.0
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
6
69
0.87
0.00
1.0
2.6
g/l
0.0
0.5
—
6
61
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
5.4
—
0.6
—
0
7
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
6
0.00
0.00
0.0
3.7
—
119.2
—
0
6
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
6
63
0.95
0.00
2.7
3.5
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
0
7
0.00
0.00
0.0
1.6
—
4.2
—
0
7
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44813793)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
8
0.00
0.00
0.0
1.1
—
6.6
—
0
8
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
6
65
0.92
0.00
1.0
2.6
g/l
31.5
37.2
—
6
57
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
44.8
—
0
5
(3029075) Extractable nuclear Ab panel - Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
7
0.00
0.00
0.0
1.0
—
5.6
—
0
7
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4211845)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
1.5
—
0
5
(3051593) INR in Capillary blood by Coagulation assay
0
9
0.00
0.00
0.0
12.7
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_DIGESTIVE_ORGANS_NAS – Malignant neoplasm of other and ill-defined digestive organs

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).